Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Viridian Therapeutics
VRDN
$1.64B
| $1.44M | ﹤0.01% |
60,700
-4,400
| -7% | -$105K |
|
|
CHS
2102
DELISTED
Chicos FAS, Inc.
CHS
| $1.44M | ﹤0.01% |
269,900
| – | – |
|
|
AGTI
2103
DELISTED
Agiliti, Inc.
AGTI
| $1.44M | ﹤0.01% |
87,400
+15,500
| +22% | +$256K |
|
2104
AvePoint
AVPT
$3.38B
| $1.44M | ﹤0.01% |
250,100
+68,800
| +38% | +$396K |
|
2105
SunCoke Energy
SXC
$659M
| $1.44M | ﹤0.01% |
182,350
+2,300
| +1% | +$18.1K |
|
2106
Eagle Bancorp
EGBN
$597M
| $1.43M | ﹤0.01% |
67,732
-1,200
| -2% | -$25.4K |
|
2107
Manitowoc
MTW
$365M
| $1.43M | ﹤0.01% |
75,950
| – | – |
|
2108
Altice USA
ATUS
$1.12B
| $1.43M | ﹤0.01% |
473,300
+6,500
| +1% | +$19.6K |
|
2109
SoundHound AI
SOUN
$5.83B
| $1.43M | ﹤0.01% |
+313,800
| New | +$1.43M |
|
|
FRG
2110
DELISTED
Franchise Group, Inc.
FRG
| $1.43M | ﹤0.01% |
49,800
-7,900
| -14% | -$226K |
|
2111
Transcat
TRNS
$700M
| $1.42M | ﹤0.01% |
16,615
+1,100
| +7% | +$93.8K |
|
2112
Steelcase
SCS
$1.94B
| $1.41M | ﹤0.01% |
183,300
-6,000
| -3% | -$46.3K |
|
2113
European Wax Center
EWCZ
$161M
| $1.41M | ﹤0.01% |
75,800
+12,300
| +19% | +$229K |
|
2114
Clearfield
CLFD
$474M
| $1.41M | ﹤0.01% |
29,800
+4,400
| +17% | +$208K |
|
2115
Amylyx Pharmaceuticals
AMLX
$1.07B
| $1.41M | ﹤0.01% |
+65,400
| New | +$1.41M |
|
2116
Anavex Life Sciences
AVXL
$791M
| $1.41M | ﹤0.01% |
173,300
+5,000
| +3% | +$40.7K |
|
2117
Symbotic
SYM
$5.51B
| $1.4M | ﹤0.01% |
32,800
+800
| +3% | +$34.2K |
|
2118
Ambac
AMBC
$412M
| $1.4M | ﹤0.01% |
98,600
+1,600
| +2% | +$22.8K |
|
2119
Cogent Biosciences
COGT
$1.78B
| $1.4M | ﹤0.01% |
118,200
+42,800
| +57% | +$507K |
|
|
HAYN
2120
DELISTED
Haynes International, Inc.
HAYN
| $1.4M | ﹤0.01% |
27,500
+400
| +1% | +$20.3K |
|
2121
Accel Entertainment
ACEL
$937M
| $1.39M | ﹤0.01% |
132,100
+9,400
| +8% | +$99.3K |
|
2122
TTEC Holdings
TTEC
$182M
| $1.39M | ﹤0.01% |
41,200
+500
| +1% | +$16.9K |
|
2123
Ethan Allen Interiors
ETD
$753M
| $1.39M | ﹤0.01% |
49,300
| – | – |
|
2124
Gray Television
GTN
$577M
| $1.39M | ﹤0.01% |
176,900
+10,800
| +7% | +$85.1K |
|
2125
Novavax
NVAX
$1.33B
| $1.39M | ﹤0.01% |
187,600
+18,100
| +11% | +$134K |
|